Postsurgical pain management is critical to keeping patients satisfied and getting them home sooner1
The ASPS supports the use of opioid-minimizing pain management strategies.
“Use of multimodal approaches should be considered over the use of single agents, particularly narcotics.”2
Achieve optimal results with proper administration volume and technique
The videos below include a variety of plastic surgeries that demonstrate how to administer EXPAREL for optimal pain control and coverage.
Abdominoplasty Animation Infiltration Surgery Performed by: Dr Rosen
For more information on EXPAREL, connect with us here
More Videos
Abdominoplasty Animation Infiltration Surgery Performed by: Dr Rosen
Surgical Site Infiltration in Delayed Latissimus Dorsi Breast Reconstruction Performed by: Dr Brzezienski
Mastectomy Performed by: Dr Valente
PECS I & II Performed by: Dr Gadsden
See how your peers use EXPAREL in case reports
ViewEXPAREL has been used across plastic surgeries from abdominoplasty and mammoplasty to breast and abdominal wall reconstruction
In cosmetic procedures
In OBESITY CLASS I MAMMOPLASTY PATIENTS vs BUPIVACAINE HCI
4 HOURS SHORTER mean length of stay (P=0.038)3*
IN ABDOMINOPLASTY AS PART OF TAP BLOCK vs STANDARD NERVE BLOCK
39% REDUCED postoperative dose of hydromorphone (2.63 mg vs 4.31 mg; P=0.024)4†‡
In RECONSTRUCTIVE procedures
In MASTECTOMY vs PRESURGICAL PARAVERTEBRAL BLOCK
24% REDUCED pain scores at discharge (3.2 vs 4.2; P<0.008)5§
IN IMPLANT-BASED BREAST RECONSTRUCTION vs BUPIVACAINE HCI
47% REDUCED postsurgical opioid consumption (0.76 MED/h vs 1.43 MED/h; P=0.017)1‡||
IN IMPLANT-BASED BREAST RECONSTRUCTION vs BUPIVACAINE HCI
36% REDUCED length of stay (29.8 hours vs 46.7 hours; P=0.035)1||
IN ABDOMINAL WALL AND BREAST RECONSTRUCTION PROCEDURES vs BUPIVACAINE HCI
29% REDUCED mean total costs ($28,021vs $39,531; P=0.02)6¶
*Retrospective review of reduction mammoplasty patients (N=113) treated with bupivacaine HCl (n=34) or EXPAREL (n=79).
†Pilot study in which abdominoplasty patients (N=32) received either EXPAREL with TAP block (n=16) or a combination of pararectus injections and ilioinguinal/iliohypogastric nerve blocks (n=16).
‡The clinical benefit of the decrease in opioid consumption was not demonstrated in pivotal trials.
§A retrospective review of patients (N=97) who underwent mastectomy with immediate tissue expander reconstruction using preoperative paravertebral block (n=53) compared with those treated with intraoperative EXPAREL infiltration (n=44).
llA prospective, randomized, single-blind trial comparing bupivacaine HCl (n=12) with EXPAREL (n=12) in patients undergoing implant-based breast reconstruction.
¶A retrospective claims analysis using the Vizient Clinical Data Base/Resource Manager abstract discharge database to identify abdominal wall and breast reconstruction procedures at participating hospitals.
ASPS; American Society of Plastic Surgeons; LOS=length of stay; MED/h=morphine equivalent dosing per hour of hospital stay; TAP=transversus abdominis plane.